Svenska
Boston
An independent LDT provider
Home
Investors
Media
Home
Media
Learn more
Press releases
Presentations
Publications
Media resources
Contact Us
Subscribe
English
Svenska
Press releases
Type
All types
Regulatory
Non regulatory
Year
All years
January 31, 2025
| REGULATORY
Change in number of shares and votes in Immunovia AB (publ)
Read press release
January 20, 2025
| REGULATORY
Immunovia AB announces outcome of exercise of warrants series TO 2
Read press release
January 8, 2025
| REGULATORY
Immunovia AB (Publ) presents Nomination Committee
Read press release
January 2, 2025
| REGULATORY
The exercise period for warrants of series TO 2 beings today
Read press release
December 27, 2024
| REGULATORY
Immunovia announces determined exercise price for warrants series TO 2 and conditionally securing 65% of the warrant programme
Read press release
December 20, 2024
Immunovia discovery study published in top protein research journal
Read press release
December 19, 2024
End of the Year 2024 Letter from Immunovia CEO Jeff Borcherding
Read press release
December 18, 2024
Immunovia CEO and board members announce intention to fully exercise their TO2 warrants
Read press release
December 16, 2024
Immunovia to host a webcast with the opportunity to learn more about the positive clinical validation of its next-generation pancreatic cancer test
Read press release
December 11, 2024
Immunovia announces financial calendar for financial year 2025/2026
Read press release
December 9, 2024
Immunovia announces positive outcome and strong accuracy in the clinical validation of its next-generation test for pancreatic cancer
Read press release
November 28, 2024
Immunovia to present at the Redeye Technology & Life Science Day
Read press release
1
2
3
…
31
>
Home
Press releases